Your browser doesn't support javascript.
loading
Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption.
Virani, Needa A; Kelada, Olivia J; Kunjachan, Sijumon; Detappe, Alexandre; Kwon, Jihun; Hayashi, Jennifer; Vazquez-Pagan, Ana; Biancur, Douglas E; Ireland, Thomas; Kumar, Rajiv; Sridhar, Srinivas; Makrigiorgos, G Mike; Berbeco, Ross I.
Afiliación
  • Virani NA; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Kelada OJ; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Kunjachan S; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Detappe A; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Kwon J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston Massachusetts, United States of America.
  • Hayashi J; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Vazquez-Pagan A; Department of Radiation Oncology, Hokkaido University, Sapporo, Japan.
  • Biancur DE; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Ireland T; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America.
  • Kumar R; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Sridhar S; Nanomedicine Innovation Center and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America.
  • Makrigiorgos GM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston Massachusetts, United States of America.
  • Berbeco RI; LA-ICP-MS and ICP-ES Laboratories, Boston University, Boston, Massachusetts, United States of America.
PLoS One ; 15(7): e0236245, 2020.
Article en En | MEDLINE | ID: mdl-32706818
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nanopartículas del Metal / Hipoxia Tumoral / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nanopartículas del Metal / Hipoxia Tumoral / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos